Brief: TCR Therapeutics Reports First Quarter 2022 Financial Results And Provides Corporate Update
12/05/2022 11:57
May 12 (Reuters) - TCR2 Therapeutics Inc TCRR.O :
* TCR² THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* EXPECT CASH ON HAND TO SUPPORT OPERATIONS INTO 2024
* QTRLY LOSS PER SHARE $0.76
* Q1 EARNINGS PER SHARE VIEW $-0.74 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbtVwCp
Further company coverage: TCRR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview